Here's Why Sorrento Therapeutics Shares Jumped 13.3% in January
Shares of Sorrento Therapeutics (NASDAQ: SRNE) gained over 13% last month, according to data provided by S&P Global Market Intelligence. On Jan. 10, the company announced it had received a nonbinding proposal from a private equity firm to be ...
from Google Alert - Business https://ift.tt/2UwsTI5
Shares of Sorrento Therapeutics (NASDAQ: SRNE) gained over 13% last month, according to data provided by S&P Global Market Intelligence. On Jan. 10, the company announced it had received a nonbinding proposal from a private equity firm to be ... https://ift.tt/eA8V8J
from Google Alert - Business https://ift.tt/2UwsTI5
Shares of Sorrento Therapeutics (NASDAQ: SRNE) gained over 13% last month, according to data provided by S&P Global Market Intelligence. On Jan. 10, the company announced it had received a nonbinding proposal from a private equity firm to be ... https://ift.tt/eA8V8J
Comments
Post a Comment